• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

    3.090 -0.040 (-1.28%)
    Streaming Delayed Price Updated: 2:17 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Sensus Healthcare, Inc. - Common Stock

    < Previous 1 2 3 Next >
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
    From Sensus Healthcare, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
    From Pomerantz LLP
    Via GlobeNewswire
    Sensus Healthcare Reports Second Quarter 2025 Financial Results
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
    From Sensus Healthcare, Inc.
    Via Business Wire
    Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Reports First Quarter 2025 Financial Results
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Participate in the 37th Annual ROTH Conference
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Buys Back Shares
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Present at The Microcap Conference 2025
    From Sensus Healthcare, Inc.
    Via Business Wire
    Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025
    From Sensus Healthcare
    Via Business Wire
    Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
    From Sensus Healthcare, Inc.
    Via GlobeNewswire
    DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
    Via ACCESSWIRE
    Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
    From Sensus Healthcare, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.